Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Sector rotation favors biotech and life sciences! BASF, MustGrow, Novo Nordisk, and BioNTech in focu

BASF – Life sciences as a growth driver in the portfolio With its life science activities, DAX giant BASF is positioning itself as a broadly diversified partner for global megatrends in nutrition, health, and sustainable agriculture. Through its Nutrition & Care and...
André Will-Laudien | 4 days ago |

Three trends, one goal: How Bayer, MustGrow Biologics, and BASF are turning the agricultural revolut

Bayer – Stable agricultural business and pharmaceuticals provide growth momentum The Leverkusen-based group has presented its figures for 2025 and achieved the targets it set in the summer. Currency-adjusted revenue rose by 1.1% to EUR 45.6 billion, while adjusted op...
Armin Schulz | 4 days ago |

US government strengthens Bayer! Almonty next? What is Novo Nordisk doing?

A bombshell at Bayer: The US government has officially sided with the Company. If the Supreme Court follows the recommendation, the Leverkusen-based company could largely put the glyphosate issue behind it as early as next year. Investors and analysts are enthusiastic. Al...
Fabian Lorenz | December 3, 2025 |

Novo Nordisk, FuelCell Energy and Almonty Industries stage strong rebound

While many analysts are concerned about high valuations on the global stock markets, with the Warren Buffett indicator at a historic high, even exceeding its value before the dot-com bubble, the markets continue to rise from one high to the next. In fact, several companie...
Stefan Feulner | October 6, 2025 |

What is happening at Gerresheimer? Almonty Industries and Rheinmetall are booming again!

In uncertain times, the focus shifts to companies that form the backbone of our critical infrastructure. Their ability to build resilient and transparent supply chains for essential goods determines our collective resilience to geopolitical and economic upheavals. Where t...
Armin Schulz | September 30, 2025 |

Bayer, Desert Gold, Snowflake – Breakout imminent

US President Donald Trump’s tariff hammer against the European Union caused stock markets to falter at the close of the trading week, but the postponement of the measures by four weeks eased tensions over the weekend. As a result, Germany’s...
Stefan Feulner | May 27, 2025 |

Buzz on the Bullboards: The 100-day checkup

This week, Canada witnessed a significant political shift as the Liberal Party made a Holyfield-esque comeback in the parliamentary elections, securing 168 seats. Although they fell short of the 172 seats needed for an outright majority, the victory marks a notable achiev...
Jonathon Brown | May 1, 2025 |

Can you get an investing edge using Emotional Intelligence?

Carolyn Stern , a certified Emotional Intelligence and Leadership Development Expert, and an award-winning author of The Emotionally Strong Leader joins The Market Online to discuss Emotional Intelligence in Investing and financial decision-making. Emotional intell...
Coreena Robertson | March 18, 2025 |

NurExone Biologic announces important test results

By Brad Sorensen, CFA, Zacks Research. NurExone Biologic (TSXV:NRX; OTCQB:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting preclinical tests for other conditions that ExoPTEN m...
Research | December 11, 2024 |

The company revolutionizing access to care and natural remedies

The Market Online recently spoke with Liz Viccars, CEO of AJA Health and Wellness Inc. (TSXV:AJA) a company transforming healthcare with its total health access service offering telemedicine, diagnostics and specialized care via proprietary tech. Additionally, AJA Heal...
Coreena Robertson | November 18, 2024 |
1 2 3 4 5 6 7 8 9 10 ...